0001181431-14-007513.txt : 20140218 0001181431-14-007513.hdr.sgml : 20140217 20140218211728 ACCESSION NUMBER: 0001181431-14-007513 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140218 FILED AS OF DATE: 20140218 DATE AS OF CHANGE: 20140218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AmpliPhi Biosciences Corp CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4870 SADLER ROAD STREET 2: SUITE 300 CITY: GLEN ALLEN STATE: VA ZIP: 23060 BUSINESS PHONE: 650-888-2422 MAIL ADDRESS: STREET 1: 4870 SADLER ROAD STREET 2: SUITE 300 CITY: GLEN ALLEN STATE: VA ZIP: 23060 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILLIAMS GWYNN CENTRAL INDEX KEY: 0000923416 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23930 FILM NUMBER: 14623825 MAIL ADDRESS: STREET 1: BALLACARRICK STREET 2: POOILVAAISH ROAD CITY: CASTLETOWN STATE: Y8 ZIP: IM9 4PJ 3 1 rrd402757.xml FORM 3 G. WILLIAMS X0206 3 2014-02-18 0 0000921114 AmpliPhi Biosciences Corp APHB 0000923416 WILLIAMS GWYNN BALLCARRICK, POOILVASSISH ROAD CASTLETOWN Y8 IM9 4PJ ISLE OF MAN 0 0 1 0 Series B Convertible Preferred Stock 2013-06-26 Common Stock 32250610 I By Pendinas Limited Warrant (right to buy) 0.14 2013-02-04 2018-02-04 Common Stock 4351816 I By Pendinas Limited Warrant (right to buy) 0.14 2013-03-12 2018-03-04 Common Stock 892857 I By Pendinas Limited Warrant (right to buy) 0.14 2013-04-12 2018-04-12 Common Stock 892857 I By Pendinas Limited Warrant (right to buy) 0.14 2013-05-13 2018-05-13 Common Stock 892857 I By Pendinas Limited The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date. Pursuant to its terms, each share of Series B Convertible Preferred Stock is convertible into ten (10) shares of Common Stock. Gwynn Williams controls Pendinas Limited. Shares held by this entity may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Act of 1934, as amended) by Mr. Williams. Mr. Williams disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. /s/ Gwynn Williams 2014-02-18 EX-24.TXT 2 rrd362490_410733.htm POWER OF ATTORNEY rrd362490_410733.html 
POWER OF ATTORNEY

	Know all by these presents that the undersigned hereby constitutes and appoints each of Philip J. Young and Kelley A. Wendt, or either of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1)	prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

(2)	execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of AmpliPhi Biosciences Corp. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(3)	do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and

(4)	take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

	This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 17th day of February, 2014.


		/s/ Gwynn Williams        		         					Signature

		Gwynn Williams